Page last updated: 2024-09-05

lasofoxifene and Menopause

lasofoxifene has been researched along with Menopause in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lawson, S; Ouyang, P; Valdiviezo, C	1
Palacios, S	1
Calaf Alsina, J; Coronado Martín, PJ	1

Reviews

2 review(s) available for lasofoxifene and Menopause

Article	Year
An update on menopausal hormone replacement therapy in women and cardiovascular disease. Current opinion in endocrinology, diabetes, and obesity, 2013, Volume: 20, Issue:2 Topics: Administration, Cutaneous; Administration, Oral; Aged; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Pyrrolidines; Randomized Controlled Trials as Topic; Receptors, Estrogen; Stroke; Tetrahydronaphthalenes; Time Factors; United States; Venous Thrombosis; Women's Health	2013
[Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action]. Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6 Topics: Adenocarcinoma; Animals; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Organ Specificity; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Thromboembolism	2013

Article

Year

An update on menopausal hormone replacement therapy in women and cardiovascular disease.

Current opinion in endocrinology, diabetes, and obesity, 2013, Volume: 20, Issue:2

Topics: Administration, Cutaneous; Administration, Oral; Aged; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Pyrrolidines; Randomized Controlled Trials as Topic; Receptors, Estrogen; Stroke; Tetrahydronaphthalenes; Time Factors; United States; Venous Thrombosis; Women's Health

2013

[Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action].

Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6

Topics: Adenocarcinoma; Animals; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Organ Specificity; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Thromboembolism

2013

Other Studies

1 other study(ies) available for lasofoxifene and Menopause

Article	Year
Selective estrogen receptor modulators: the future in menopausal treatment. Minerva ginecologica, 2011, Volume: 63, Issue:3 Topics: Female; Forecasting; Humans; Indoles; Menopause; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes	2011